MBX Biosciences Statistics
NASDAQ: MBXHealthcareBiotechnologyUSD
54.54-2.38 (-4.18%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
MBX Biosciences by the numbers
MBX Biosciences has a market capitalization of $2.63 billion based on 48.16M shares outstanding. With trailing EPS of $-2.27, MBX Biosciences is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 13.5% below its 50-day average and 24.5% above its 200-day average.
Average daily trading volume is 556.72K shares, or about $30.4 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
MBX valuation vs. peer median
| Metric | MBX | Peer median | Difference |
|---|---|---|---|
| Market cap | $2.63B | $2.06B | +28% |
| Avg. volume | 556.72K | 1.52M | -63% |
Peer median across 8 companies: NAMS, DNLI, AUPH, URGN, TRVI, ADRX, NVAX, TNGX.
Valuation
- Market cap
- $2.63B
- EPS (TTM)
- $-2.27
- Shares outstanding
- 48.16M
Price and trading
- Previous close
- 56.92
- Open
- 56.38
- Day range
- 53.36 – 58.50
- 52-week range
- 12.94 – 72.64
- 52-week change
- +245.19%
- Beta
- —
- Volume
- 355.11K
- Average volume
- 556.72K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 2.63B
- Forward Pe
- -13.72
- Eps
- -2.27
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 72.64
- Week52 Low
- 12.94
- Avg Volume
- 556.72K
- Shares Outstanding
- 48.16M
- Ma50
- 63.03
- Ma200
- 43.80
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -24.92%
- Pct From52w Low
- 321.48%